Literature DB >> 27908358

Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.

Joshua D Brown, Anand R Shewale, Parinita Dherange, Jeffery C Talbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27908358     DOI： 10.1016/j.jacc.2016.06.082

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

1.  Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?

Authors:  Phuong N Pham; Joshua D Brown
Journal:  BMC Cardiovasc Disord       Date:  2019-03-19       Impact factor: 2.298

2.  Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data.

Authors:  Joshua D Brown; Anand R Shewale; Jeffery C Talbert
Journal:  J Manag Care Spec Pharm       Date:  2017-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.